|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：A637200 |
| 產(chǎn)品名稱：Anacetrapib |
| 產(chǎn)品CAS：875446-37-0 |
| 規(guī)格含量： |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
A637200 |
| 名稱: |
Anacetrapib |
| 別名: |
(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-2'-methoxy-5'-(1-methylethyl)-4-(trifluoromethyl)[1,1'-biphenyl]-2-yl]methyl]-4-methyl-2-oxazolidinone; (4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one; MK 0859 |
| CAS號(hào): |
875446-37-0 |
| 分子式: |
C??H??F??NO? |
| 分子量: |
637.51 |
| 類別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
An orally active and potent cholesterol ester transfer protein (CETP) inhibitor for the treatment of atherosclerosis, in particular dyslipidemia. |
| 文獻(xiàn) |
|
|
|
|
?您的位置：
